Results 291 to 300 of about 355,018 (412)
Isolation and Characterization of a <i>Klebsiella</i> Phage H33IIK Targeting Multidrug-Resistant <i>Klebsiella pneumoniae</i> in Peru. [PDF]
Aguilar-Ancori E +5 more
europepmc +1 more source
Mitochrial transplantation is a promising therapy to restore energy in damaged cells, but it lacks fast and reliable methods to assess mitochondrial quality before use. In this study, we used a label‐free imaging technique called interferometric light microscopy to rapidly measure the size and concentration of isolated mitochondria.
Sabah Mozafari +5 more
wiley +1 more source
Genome Sequence of <i>Arthrobacter</i> Phage KNG13. [PDF]
Grahmann K +19 more
europepmc +1 more source
Host receptors for bacteriophage adsorption.
Juliano Bertozzi Silva +2 more
semanticscholar +1 more source
Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity
Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin +3 more
wiley +1 more source
Characterization of the Fiber Protein C-Terminal Domain from <i>Klebsiella pneumoniae</i> Phage KlebP_144 and Evaluation of Its Anti-Capsular Activity. [PDF]
Kravchuk BI +8 more
europepmc +1 more source
Nonthermal plasma approaches for combating implant‐associated infections: A compendious review
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe +8 more
wiley +1 more source
Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport. [PDF]
Islam MS +8 more
europepmc +1 more source

